Literature DB >> 18835922

Nerve stimulation induced overflow of neuropeptide Y and modulation by angiotensin II in spontaneously hypertensive rats.

Mirnela Byku1, Heather Macarthur, Thomas C Westfall.   

Abstract

The sympathetic nervous system and renin-angiotensin system are both thought to contribute to the development and maintenance of hypertension in experimental models such as the spontaneously hypertensive rat (SHR). We demonstrated that periarterial nerve stimulation (NS) increased the perfusion pressure (PP) and neuropeptide Y (NPY) overflow from perfused mesenteric arterial beds of SHRs at 4-6, 10-12, and 18-20 wk of age, which correspond to prehypertensive, developing hypertensive, and maintained hypertensive stages, respectively, in the SHR. NS also increased PP and NPY overflow from mesenteric beds of Wistar-Kyoto (WKY) normotensive rats. NS-induced increases in PP and NPY were greater in vessels obtained from SHRs of all three ages compared with WKY rats. ANG II produced a greater increase in PP in preparations taken from SHRs than WKY rats. ANG II also resulted in a greater increase in basal NPY overflow from 10- to 12-wk-old and 18- to 20-wk-old SHRs than age-matched WKY rats. ANG II enhanced the NS-induced overflow of NPY from SHR preparations more than WKY controls at all ages studied. The enhancement of NS-induced NPY overflow by ANG II was blocked by the AT1 receptor antagonist EMD-66684 and the angiotensin type 2 receptor antagonist PD-123319. In contrast, ANG II greatly enhanced norepinephrine overflow in the presence of PD-123319. Both captopril and EMD-66684 decreased neurotransmitter overflow from SHR mesenteric beds; therefore, we conclude that an endogenous renin-angiotensin system is active in this preparation. It is concluded that the ANG II-induced enhancement of sympathetic nerve stimulation may contribute to the development and maintenance of hypertension in the SHR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18835922      PMCID: PMC2614567          DOI: 10.1152/ajpheart.00384.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  71 in total

1.  Plasma catecholamines and dopamine-beta-hydroxylase activity in spontaneously hypertensive rats.

Authors:  M F Roizen; V Weise; H Grobecker; I J Kopin
Journal:  Life Sci       Date:  1975-07-15       Impact factor: 5.037

Review 2.  Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation.

Authors:  Robert M Carey; Helmy M Siragy
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

3.  Action of angiotensin on vascular adrenergic nerve endings: facilitation of norepinephrine release.

Authors:  B G Zimmerman; S K Gomer; J C Liao
Journal:  Fed Proc       Date:  1972 Jul-Aug

4.  Nitric oxide decreases the biological activity of norepinephrine resulting in altered vascular tone in the rat mesenteric arterial bed.

Authors:  Lacy L Kolo; Thomas C Westfall; Heather Macarthur
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-01       Impact factor: 4.733

5.  Modulation of neurotransmitter release by NO is altered in mesenteric arterial bed of spontaneously hypertensive rats.

Authors:  Lacy L Kolo; Thomas C Westfall; Heather Macarthur
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-06-17       Impact factor: 4.733

6.  AT1 and AT2-receptor antagonists inhibit Ang II-mediated facilitation of noradrenaline release in human atria.

Authors:  Malek El Muayed; Johannes Stegbauer; Vitus Oberhauser; Oliver Vonend; Lars Christian Rump
Journal:  J Cardiovasc Pharmacol       Date:  2004-02       Impact factor: 3.105

7.  Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice.

Authors:  Peter M Abadir; Robert M Carey; Helmy M Siragy
Journal:  Hypertension       Date:  2003-09-02       Impact factor: 10.190

8.  No involvement of the AT2-receptor in angiotensin II-enhanced sympathetic transmission in vitro.

Authors:  Alexander Nap; Jippe C Balt; Martin Pfaffendorf; Pieter A van Zwieten
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2003-06       Impact factor: 1.636

9.  Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats.

Authors:  Kathryn A Gradin; Jia-Yi Li; Ove Andersson; Ulf Simonsen
Journal:  J Vasc Res       Date:  2003 May-Jun       Impact factor: 1.934

Review 10.  ACE2, a new regulator of the renin-angiotensin system.

Authors:  Louise M Burrell; Colin I Johnston; Christos Tikellis; Mark E Cooper
Journal:  Trends Endocrinol Metab       Date:  2004 May-Jun       Impact factor: 12.015

View more
  5 in total

1.  Effect of dipeptidyl peptidase 4 inhibition on arterial blood pressure is context dependent.

Authors:  Edwin K Jackson; Zaichuan Mi; Stevan P Tofovic; Delbert G Gillespie
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Sympathetic nerves and the endothelium influence the vasoconstrictor effect of low concentrations of ouabain in pressurized small arteries.

Authors:  Hema Raina; Qingli Zhang; Albert Y Rhee; Thomas L Pallone; W Gil Wier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

Review 3.  Neuronal and non-neuronal modulation of sympathetic neurovascular transmission.

Authors:  H Macarthur; G H Wilken; T C Westfall; L L Kolo
Journal:  Acta Physiol (Oxf)       Date:  2011-03-01       Impact factor: 6.311

4.  Inhibitory effects of angiotensin-(1-7) on the nerve stimulation-induced release of norepinephrine and neuropeptide Y from the mesenteric arterial bed.

Authors:  Mirnela Byku; Heather Macarthur; Thomas C Westfall
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-20       Impact factor: 4.733

5.  The Type of Fat in the Diet Influences Regulatory Aminopeptidases of the Renin-Angiotensin System and Stress in the Hypothalamic-Pituitary-Adrenal Axis in Adult Wistar Rats.

Authors:  Germán Domínguez-Vías; Ana Belén Segarra; Manuel Ramírez-Sánchez; Isabel Prieto
Journal:  Nutrients       Date:  2021-11-04       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.